GRNA 0.00 GreenLight Biosciences Holdings
| Range: | 0.177-5.9 | Vol Avg: | 684804 | Last Div: | 0 | Changes: | 0 |
| Beta: | 1.44 | Cap: | 0.05B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Feb 03 2022 | Empoloyees: | 280 | ||
| CUSIP: | 39536G105 | CIK: | 0001822691 | ISIN: | US39536G1058 | Country: | US |
| CEO: | Dr. Andrey Juan Zarur Ph.D. | Website: | https://greenlightbiosciences.com | ||||
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow